Impact of change in level of risk factor(s) and proportion of cured/immune individuals on the population attributable risk : simulation based study /

Impact of change in level of risk factor(s) and proportion of cured/immune individuals on the population attributable risk : simulation based study /

Bibliographic Details
Main Author:	Mandrekar, Jayawant Narayan
Language:	English
Published:	The Ohio State University / OhioLINK 2002
Subjects:	Biology Clinical trials
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1486462067843814

Similar Items

Prevention Is Better Than the Cure: Risk Management of COVID-19
by: Michael McAleer
Published: (2020-03-01)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
by: Filipa Júlio, et al.
Published: (2021-08-01)

Why Is There No Cure for Tinnitus?
by: Don J. McFerran, et al.
Published: (2019-08-01)

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
by: Sonia M. Vallabh, et al.
Published: (2020-06-01)

Capsaicin Supplementation Improved Risk Factors of Coronary Heart Disease in Individuals with Low HDL-C Levels
by: Yu Qin, et al.
Published: (2017-09-01)

Some data quality issues at ClinicalTrials.gov
by: Neha Chaturvedi, et al.
Published: (2019-06-01)

How implementation of systems biology into clinical trials accelerates understanding of diseases
by: Bibiana eBielekova, et al.
Published: (2014-06-01)

Small cross-sectional survey of composite restoration attributes associated with choices for replacement
by: Alessandra Ramos Parpaiola, et al.
Published: (2009-09-01)

Designing clinical trials
by: Smita Narayan
Published: (2021-01-01)

Pharmacokinetic Evaluation by Modeling and Simulation Analysis of a Donepezil Patch Formulation in Healthy Male Volunteers
by: Yoon SK, et al.
Published: (2020-05-01)

What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent
by: Holly L. Peay, et al.
Published: (2015-01-01)

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
by: Paul W. Denton, et al.
Published: (2019-08-01)

Salivary microbiota in individuals with different levels of caries experience
by: Daniel Belstrøm, et al.
Published: (2017-01-01)

Current evidence linking polyunsaturated fatty acids (PUFAs) with cancer risk and progression
by: Maria eAzrad, et al.
Published: (2013-09-01)

COVID-19 effect on clinical research: Single-site risk management experience
by: Fatma Soliman Elsayed Ebeid
Published: (2020-01-01)

From bench to clinical trials the EORTC experience in biology-based clinical cancer research
by: Konstantinos Tryfonidis, et al.
Published: (2017-12-01)

A landscape analysis of HIV cure-related clinical trials and observational studies in 2018
by: Liz Barr, et al.
Published: (2019-10-01)

Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
by: J. Fraser Wright
Published: (2014-03-01)

Quality expectations and tolerance limits of trial master files (TMF) – Developing a risk-based approach for quality assessments of TMFs
by: Hecht, Arthur, et al.
Published: (2015-12-01)

OncoPDSS: an evidence-based clinical decision support system for oncology pharmacotherapy at the individual level
by: Quan Xu, et al.
Published: (2020-08-01)

Searching for cures: Inner-city and rural patients' awareness and perceptions of cancer clinical trials
by: Mugur Geana, et al.
Published: (2017-03-01)

Understanding noninferiority trials
by: Seokyung Hahn
Published: (2012-11-01)

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study
by: Marion Fiorentino, et al.
Published: (2019-07-01)

Risk based monitoring does not reduce the cost of clinical trials
by: I. V. Stefanov
Published: (2018-05-01)

PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
by: S. A. Shalnova, et al.
Published: (2005-08-01)

Risks associated with the ethical aspects of conducting clinical trials
by: A. L. Khokhlov, et al.
Published: (2020-05-01)

The effects of an after-school intervention program on physical activity level, sedentary time, and cardiovascular risk factors in adolescents
by: Roseane de Fátima Guimarães, et al.
Published: (2017-11-01)

Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov
by: Yanfang Gao, et al.
Published: (2021-06-01)

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
by: Lagaay A Margot, et al.
Published: (2002-05-01)

Registered Interventional Clinical Trials for Old Populations With Infectious Diseases on ClinicalTrials.gov: A Cross-Sectional Study
by: Lingmin Chen, et al.
Published: (2020-06-01)

The appearance and increase in the quantity and proportion of the clinical research coordinator’s service fee in drug clinical trial research fund and its impact on trial quality
by: Liran Chen, et al.
Published: (2021-07-01)

NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome
by: Debbie S. Gipson, et al.
Published: (2018-03-01)

Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
by: Edgardo Rodríguez-Torres, et al.
Published: (2021-09-01)

Unapproved clinical trials in Russia: exception or norm?
by: Petr Talantov, et al.
Published: (2021-04-01)

Design considerations for early-phase clinical trials of immune-oncology agents
by: Nolan A. Wages, et al.
Published: (2018-08-01)

Ambassadors of hope, research pioneers and agents of change—individuals’ expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study
by: Julia Lawton, et al.
Published: (2019-05-01)

Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01)

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials
by: Josef Smolen, et al.
Published: (2019-11-01)

The Impact of Smoking on Psoriasis Patients with Biological Therapies in a Bucharest Hospital
by: Maria-Magdalena Constantin, et al.
Published: (2021-07-01)

Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)
by: Nikola A. Ivica, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_mrck6e5geb6fc4ebhdrreae738